DIVERSIFIED HEALTHCARE TRUST - Common Shares of Beneficial Interest (DHC)

CUSIP: 25525P107

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-3,780,022
Put/Call ratio
180%
SEC-reported price per share
$3.58
Number of holders
191
Value change
-$12,470,705
Number of buys
82
Open additional details 1 more signal available
Number of sells
79
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
242,134,041

Security key

25525P107

Report period

Q2 2025

Institutions

191

Top holders

10

Ownership snapshot

Top reported holders of DHC - DIVERSIFIED HEALTHCARE TRUST - Common Shares of Beneficial Interest (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Flat Footed LLC
Disclosed value leader
Flat Footed LLC
Comparable rows
0/15
Latest evidence
31 Mar 2025
13F Highest disclosed value: $56,368,799 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Flat Footed LLC has the largest disclosed position value at $56.37M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flat Footed LLC's linked filing trail.
Disclosed position value Top 5
Flat Footed LLC $56.37M
VANGUARD GROUP INC $47.27M
BlackRock, Inc. $46.64M
Silver Point Capital L.P. $37.21M
H/2 CREDIT MANAGER LP $35.8M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Flat Footed LLC
13F
Company
13F
—
denominator unverified
$56,368,799
23,487,000 shares
— 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$47,273,652
19,697,355 shares
— 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$46,643,532
19,434,806 shares
— 31 Mar 2025
Silver Point Capital L.P.
13F
Company
13F
—
denominator unverified
$37,211,544
15,504,810 shares
— 31 Mar 2025
H/2 CREDIT MANAGER LP
13F
Company
13F
—
denominator unverified
$35,802,000
14,917,366 shares
— 31 Mar 2025
D. E. Shaw & Co., Inc.
13F
Company
13F
—
denominator unverified
$24,603,245
10,251,352 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
191
Shares
181,050,325
Rows available
191
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
201
Q2 2025 holders
191
Holder diff
-10
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .